Among the candidate target genes, we focused on runt-related transcription factor 2 (Runx2) an oncogene, which was reportedly overexpressed in ovarian cancer tissues [21], as a potential target of miR-218. This evidence concerns the gene RUNX2 and ovarian cancer.